NEW ENGLAND JOURNAL OF MEDICINE (NEJM) TO PUBLISH RESULTS FROM SAVARA’S PIVOTAL PHASE 3 IMPALA-2 CLINICAL TRIAL IN AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS (AUTOIMMUNE PAP)
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.